Mintz

We are proud to have represented the underwriter in Precision BioSciences, Inc.'s $75 million registered direct offering. The Mintz capital markets team included William Hicks, John Rudy, Alok Choksi, Gianna Nappi, and Christopher Kinney. Joanne Hawana provided regulatory advice; James Whittle and James McCann, PhD provided intellectual property advice; and Ari Feder provided tax advice. https://lnkd.in/eBRxxBPY

Mintz was proud to partner with the Transnational Justice Project at the University of Toronto, the International Bar Association and the 1834 Foundation to host the Black Students’ Law Reception at our Toronto office. This inspiring event welcomed 80 students eager to explore careers in law and provided a unique opportunity to: - Build awareness of international legal careers - Create meaningful mentorship and networking connections - Advance diversity and inclusion in global legal practice Special thanks to our client OPTrust for helping make this event possible and to all the speakers and mentors who shared their insights and career journeys. Together, we’re building pathways for the next generation of diverse legal professionals.

This week we celebrated Veterans Day and Remembrance Day, honoring the courage, sacrifice, and dedication of those who have served in the US and Canadian Armed Forces. We are proud to share stories from our Mintz veterans and extend our deepest gratitude for their service.

Mintz advised the underwriters in connection with Benitec Biopharma Inc.'s follow-on public offering of 5,930,000 shares of common stock at a public offering price of $13.50 per share, and the placement agents in the concurrent registered direct offering of 1,481,481 shares of common stock at an offering price of $13.50 per share. The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, Allyson Wilkinson, Jessica Zhang (张亨), and Kate McLeod. Joanne Hawana provided regulatory advice, and Serge Banini and Samantha Pilicer, Ph.D. provided intellectual property advice. Members of the Mintz team are based in the Boston, New York, Washington, DC, and San Francisco offices. https://lnkd.in/e_BnVAn5

Mintz advised the underwriter in connection with a $75 million underwritten offering by MoonLake Immunotherapeutics (NASDAQ: MLTX) of 7,142,857 Class A ordinary shares at an offering price of $10.50 per share. The Mintz capital markets team included William Hicks, John Rudy, Nishant Dharia, Allyson Wilkinson, Gianna Nappi, Jocelyn Sun, and Emily Dougherty. Joanne Hawana provided regulatory advice, and Terri Shieh-Newton and Evelyne Guillouet-Walters provided intellectual property advice. Members of the Mintz team are based in the Boston, New York, Washington, DC, San Diego, and San Francisco offices. https://lnkd.in/eq5Cf9yZ

Congratulations to our client Flightpath Biosciences, Inc on expanding its pipeline with a new clinical‑stage product license from Northeastern University.   This milestone highlights its commitment to advancing precision anti‑infectives through innovative science and collaboration. FP530 (Formibactin A) represents an exciting step forward in tackling disease‑driving bacteria while preserving the microbiome. We’re proud to support Flightpath on its journey and look forward to what’s ahead as it continues to grow and innovate.

Benchmark Litigation has recognized 19 Mintz attorneys in its 2026 guide and named Mintz a Highly Recommended Firm in Massachusetts. The firm also achieved national Tier 2 rankings in the Commercial Litigation, Insurance, and White Collar categories. The following Mintz attorneys were individually recognized in the 2026 guide: Nancy D. Adams, CPCU, Kevin Ainsworth, Douglas Baumstein, Suman Chakraborty, Peter A. Chavkin, Francis Earley, Scott Ford, Kelly Frey, Michael Gardener, Siegmund (Sige) Gutman, Jacob Hupart, Emily Musgrave, Mark W. Lerner, Michelle Lipkowitz, Kim Marrkand, Todd Rosenbaum, Natashia Tidwell, Thomas Wintner, and Alec Zadek. https://lnkd.in/emKCs5j2

Forbes featured insights from Of Counsel Michelle Capezza in an article about the distinction between risk capacity and risk tolerance in retirement planning. The article notes that while many retirement plan participants intuitively understand the concept of risk capacity, its nuances are not always reflected in the risk assessment tools available through 401(k) plans due to fiduciary liability concerns. Michelle says, “An assessment of risk capacity is more of an objective assessment regarding how much risk a person can take based on their financial situation, considering such things as their income and expenses, assets and liabilities, time horizon, goals, and other obligations. An assessment of risk tolerance is more of a subjective gauge regarding an individual’s willingness to take on risk, and how much risk they would be comfortable taking on.” https://lnkd.in/g_hQvzcf

Investment Funds Practice Chair Kari Harris was quoted in a Buyouts article about how private equity firms are increasingly turning to alternative sources of capital amid a slowdown in traditional fundraising. One strategy gaining traction is the recycling of proceeds from asset sales into new investments, which many funds have become more flexible with. “Historically, there’s been a really narrowed definition of dollars that could be recycled and may or may not have an overcommitment cap. The current trend is a broader ability to recycle dollars,” Kari says. https://lnkd.in/eQuXbhsq